Christopher Primiano | SVP, Operations & Business Development, General Counsel and Secretary |
Michael Kauffman | CEO |
Michael Falvey | CFO |
Jatin Shah | VP, Clinical Strategy |
Mike King | JMP Securities |
Brian Abrahams | RBC Capital |
Arlinda Lee | Canaccord |
Maury Raycroft | Jefferies |
Ed White | H.C. Wainwright & Co. |
Eric Joseph | JPMorgan |
Good morning. My name is Iva, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Year-End 2017 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Mr.